مجله انجمن آنستزیولوژی و مراقبت‌های ویژه ایران

International Diabetes Federation. IDF diabetes atlas. 10th edn. Brussels, Belgium: IDF; 2021

Frisch A, Chandra P, Smiley D, Peng L, Rizzo M, Gatcliffe C, et al. Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery. Diabetes care. 2010 Aug 1;33(8):1783-8.

Clement S, Braithwaite SS, Magee MF, Ahmann A, Smith EP, Schafer RG, et al, Diabetes in Hospitals Writing Committee. Management of diabetes and hyperglycemia in hospitals. Diabetes care. 2004 Feb 1;27(2):553-91.

Fowler AJ, Wahedally MH, Abbott TE, Smuk M, Prowle JR, Pearse RM, et al. Death after surgery among patients with chronic disease: prospective study of routinely collected data in the English NHS. British Journal of Anaesthesia. 2022 Feb 1;128(2):333-42.

Centre for Perioperative Care (CPOC). Guideline for perioperative care for people with diabetes mellitus undergoing elective and emergency surgery 2021.

Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 2006; 332: 73e8

Estrada CA, Young JA, Nifong LW, Chitwood WR. Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting. Ann Thorac Surg 2003; 75: 1392e9

Membership of the Working Party, Barker P, Creasey PE, Dhatariya K, Levy N, Lipp A, et al. Peri‐operative management of the surgical patient with diabetes 2015: Association of Anaesthetists of Great Britain and Ireland. Anaesthesia. 2015 Dec;70(12):1427-40.

American Diabetes Association. Committee ADAPP. 2. Classification and diagnosis of diabetes: Standards of medical Care in diabetes e 2022. Diabetes Care 2022; 45: S17e38

Drayton DJ, Birch RJ, D’Souza-Ferrer C, Ayres M, Howell SJ, Ajjan RA. Diabetes mellitus and perioperative outcomes: a scoping review of the literature. Br J Anaesth 2022; 128: 817e28

Hulst AH, Polderman JA, Kooij FO, Vittali D, Lirk P, Hollmann MW, et al. Comparison of perioperative glucose regulation in patients with type 1 vs type 2 diabetes mellitus: A retrospective cross‐sectional study. Acta Anaesthesiologica Scandinavica. 2019 Mar;63(3):314-21.

van Wilpe R, Hulst AH, Siegelaar SE, DeVries JH, Preckel B, Hermanides J. Type 1 and other types of diabetes mellitus in the perioperative period. What the anaesthetist should know. J Clin Anesth 2023; 84, 111012

Burgess LH, Kramer J, Castelein C, Parra JM, Timmons V, Pickens S, et al. Pharmacy-led medication reconciliation program reduces adverse drug events and improves satisfaction in a community hospital. HCA Healthcare Journal of Medicine. 2021;2(6):411.

Gasanova I, Meng J, Minhajuddin A, Melikman E, Alexander JC, Joshi GP. Preoperative continuation versus interruption of oral hypoglycemics in type 2 diabetic patients undergoing ambulatory surgery: a randomized controlled trial. Anesth Analg 2018; 127: e54e6

Hulst AH, Polderman JA, Ouweneel E, Pijl AJ, Hollmann MW, DeVries JH, et al. Peri‐operative continuation of metformin does not improve glycaemic control in patients with type 2 diabetes: A randomized controlled trial. Diabetes, Obesity and Metabolism. 2018 Mar;20(3):749-52.

Stubbs DJ, Levy N, Dhatariya K. Diabetes medication pharmacology. BJA Educ 2017; 17: 198e207

Kaneko S, Ueda Y, Tahara Y. GLP1 receptor agonist liraglutide is an effective therapeutic option for perioperative glycemic control in type 2 diabetes within Enhanced Recovery after Surgery (ERAS) protocols. Eur Surg Res 2018; 59: 349e60

Makino H, Tanaka A, Asakura K, Koezuka R, Tochiya M, Ohata Y, et al. Addition of low‐dose liraglutide to insulin therapy is useful for glycaemic control during the peri‐operative period: effect of glucagon‐like peptide‐1 receptor agonist therapy on glycaemic control in patients undergoing cardiac surgery (GLOLIA study). Diabetic Medicine. 2019 Dec;36(12):1621-8.

Polderman JA, Van Steen SC, Thiel B, Godfried MB, Houweling PL, Hollmann MW, et al. Peri‐operative management of patients with type‐2 diabetes mellitus undergoing non‐cardiac surgery using liraglutide, glucose–insulin–potassium infusion or intravenous insulin bolus regimens: a randomised controlled trial. Anaesthesia. 2018 Mar;73(3):332-9.

Hulst AH, Visscher MJ, Godfried MB, Thiel B, Gerritse BM, Scohy TV, et al. Liraglutide for perioperative management of hyperglycaemia in cardiac surgery patients: a multicentre randomized superiority trial. Diabetes, Obesity and Metabolism. 2020 Apr;22(4):557-65.

Vellanki P, Rasouli N, Baldwin D, Alexanian S, Anzola I, Urrutia M, et al. Glycaemic efficacy and safety of linagliptin compared to a basal‐bolus insulin regimen in patients with type 2 diabetes undergoing non‐cardiac surgery: A multicentre randomized clinical trial. Diabetes, Obesity and Metabolism. 2019 Apr;21(4):837-43.

Cardona S, Tsegka K, Pasquel FJ, Jacobs S, Halkos M, Keeling WB, et al. Sitagliptin for the prevention and treatment of perioperative hyperglycaemia in patients with type 2 diabetes undergoing cardiac surgery: A randomized controlled trial. Diabetes, Obesity and Metabolism. 2021 Feb;23(2):480-8.

Scholtes RA, van Baar MJB, Lytvyn Y, et al. Sodium glucose cotransporter (SGLT)-2 inhibitors: do we need them for glucose-lowering, for cardiorenal protection or both? Diabetes Obes Metab 2019; 21: 24e33

Musso G, Saba F, Cassader M, Gambino R. Diabetic ketoacidosis with SGLT2 inhibitors. BMJ 2020; 371: m4147

Mehta PB, Robinson A, Burkhardt D, Rushakoff RJ. Inpatient perioperative euglycemic diabetic ketoacidosis due to sodium-glucose cotransporter-2 inhibitors d lessons from a case series and strategies to decrease incidence. Endocr Pract 2022; 28: 884e8

Halvorsen S, Mehilli J, Cassese S, Hall TS, Abdelhamid M, Barbato E, et al. 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery: Developed by the task force for cardiovascular assessment and management of patients undergoing non-cardiac surgery of the European Society of Cardiology (ESC) Endorsed by the European Society of Anaesthesiology and Intensive Care (ESAIC). European heart journal. 2022 Oct 14;43(39):3826-924.

Joshi GP, Chung F, Vann MA, Ahmad S, Gan TJ, Goulson DT, et al. Society for Ambulatory Anesthesia consensus statement on perioperative blood glucose management in diabetic patients undergoing ambulatory surgery. Anesthesia & Analgesia. 2010 Dec 1;111(6):1378-87.

Alberti KG, Thomas DJ. The management of diabetes during surgery. Br J Anaesth 1979; 51: 693e710

Nixon R, Folwell R, Pickup JC. Variations in the quality and sustainability of long-term glycaemic control with continuous subcutaneous insulin infusion. Diabet Med 2014; 31: 1174e7

Hoogma RP, Hammond PJ, Gomis R, Kerr D, Bruttomesso D, Bouter KP, et al. Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH‐based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5‐nations trial. Diabetic Medicine. 2006 Feb;23(2):141-7.

Orr CJ, Hopman W, Yen JL, Houlden RL. Long-term efficacy of insulin pump therapy on glycemic control in adults with type 1 diabetes mellitus. Diabetes Technol Ther 2015; 17: 49e54

Boyle ME, Seifert KM, Beer KA, Apsey HA, Nassar AA, Littman SD, et al. Guidelines for application of continuous subcutaneous insulin infusion (insulin pump) therapy in the perioperative period. Journal of diabetes science and technology. 2012 Jan;6(1):184-90.

Fresa R, Visalli N, Di Blasi V, Cavallaro V, Ansaldi E, Trifoglio O, et al. Experiences of continuous subcutaneous insulin infusion in pregnant women with type 1 diabetes during delivery from four Italian centers: a retrospective observational study. Diabetes technology & therapeutics. 2013 Apr 1;15(4):328-34.

Partridge H, Perkins B, Mathieu S, Nicholls A, Adeniji K. Clinical recommendations in the management of the patient with type 1 diabetes on insulin pump therapy in the perioperative period: a primer for the anaesthetist. Br J Anaesth 2016; 116: 18e26

Herzig D, Suhner S, Roos J, Schürch D, Cecchini L, Nakas CT, et al. Perioperative fully closed-loop insulin delivery in patients undergoing elective surgery: an open-label, randomized controlled trial. Diabetes Care. 2022 Sep 1;45(9):2076-83.

Krishnasamy S, Abell TL. Diabetic gastroparesis: principles and current trends in management. Diabetes Ther 2018; 9: 1e42

Zhou L, Yang Y, Yang L, Cao W, Jing H, Xu Y, et al. Point-of-care ultrasound defines gastric content in elective surgical patients with type 2 diabetes mellitus: a prospective cohort study. BMC anesthesiology. 2019 Dec;19:1-9.

Bouvet L, Desgranges FP, Aubergy C, Boselli E, Dupont G, Allaouchiche B, et al. Prevalence and factors predictive of full stomach in elective and emergency surgical patients: a prospective cohort study. BJA: British Journal of Anaesthesia. 2017 Mar 1;118(3):372-9.

Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med 2001; 161: 1989e96

Xiao MZX, Englesakis M, Perlas A. Gastric content and perioperative pulmonary aspiration in patients with diabetes mellitus: a scoping review. Br J Anaesth 2021; 127: 224e35

Jackson MJ, Patvardhan C, Wallace F, Martin A, Yusuff H, Briggs G, Malik RA, et al. Perioperative management of diabetes in elective patients: a region-wide audit. BJA: British Journal of Anaesthesia. 2016 Apr 1;116(4):501-6.

Hokka M, Egi M, Mizobuchi S. Glycated hemoglobin A1c level on the day of emergency surgery is a marker of premorbid glycemic control: a retrospective observational study. BMC Anesthesiol 2018; 18: 180

Kopp Lugli A, Marti WR, Salm L, Mujagic E, Bundi M, von Strauss M, et al. The role of HbA1c as a positive perioperative predictor of surgical site and other postoperative infections: an explorative analysis in patients undergoing minor to major surgery. World Journal of Surgery. 2022 Feb;46(2):391-9.

Kwon S, Thompson R, Dellinger P, Yanez D, Farrohki E, Flum D. Importance of perioperative glycemic control in general surgery: a report from the Surgical Care and Outcomes Assessment Program. Ann Surg 2013; 257: 8e14

Gruenbaum SE, Toscani L, Fomberstein KM, Ruskin KJ, Dai F, Qeva E, et al. Severe intraoperative hyperglycemia is independently associated with postoperative composite infection after craniotomy: an observational study. Anesthesia & Analgesia. 2017 Aug 1;125(2):556-61.

Umpierrez GE, Smiley D, Jacobs S, Peng L, Temponi A, Mulligan P, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes care. 2011 Feb 1;34(2):256-61.

Gandhi GY, Nuttall GA, Abel MD, Mullany CJ, Schaff HV, O'Brien PC, et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Annals of internal medicine. 2007 Feb 20;146(4):233-43.

Nice-Sugar Study Investigators. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine. 2009 Mar 26;360(13):1283-97.

Pomposelli JJ, Baxter III JK, Babineau TJ, Pomfret EA, Driscoll DF, Forse RA, et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. Journal of Parenteral and Enteral Nutrition. 1998 Mar;22(2):77-81.

Umpierrez G, Cardona S, Pasquel F, Jacobs S, Peng L, Unigwe M, et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary artery bypass graft surgery: GLUCO-CABG trial. Diabetes care. 2015 Sep 1;38(9):1665-72.

De Vries FE, Gans SL, Solomkin JS, Allegranzi B, Egger M, Dellinger EP, et al. Meta-analysis of lower perioperative blood glucose target levels for reduction of surgical-site infection. Journal of British Surgery. 2017 Jan;104(2):e95-105.

Cardona S, Pasquel FJ, Fayfman M, Peng L, Jacobs S, Vellanki P, et al. Hospitalization costs and clinical outcomes in CABG patients treated with intensive insulin therapy. Journal of Diabetes and its Complications. 2017 Apr 1;31(4):742-7.

Bohé J, Abidi H, Brunot V, Klich A, Klouche K, Sedillot N, et al. Individualised versus conventional glucose control in critically-ill patients: the CONTROLING study—a randomized clinical trial. Intensive care medicine. 2021 Nov;47:1271-83.

Kim SH, Hwang JH. Preoperative glycosylated haemoglobin as a predictor of postoperative analgesic requirements in diabetic patients: a prospective observational study. Eur J Anaesthesiol 2015; 32: 705e11

Garg R, Hurwitz S, Rein R, Schuman B, Underwood P, Bhandari S. Effect of follow-up by a hospital diabetes care team on diabetes control at one year after discharge from the hospital. Diabetes Res Clin Pract 2017; 133: 78e84

Corcoran TB, O’Loughlin E, Chan MTV, Ho KM. Perioperative ADministration of Dexamethasone and blood Glucose concentrations in patients undergoing elective non-cardiac surgery d the randomised controlled PADDAG trial. Eur J Anaesthesiol 2021; 38: 932e42

Low Y, White WD, Habib AS. Postoperative hyperglycemia after 4- vs 8e10-mg dexamethasone for postoperative nausea and vomiting prophylaxis in patients with type II diabetes mellitus: a retrospective database analysis. J Clin Anesth 2015; 27: 589e94

Corcoran TB, Myles PS, Forbes AB, O'Loughlin E, Leslie K, Story D, et al. The perioperative administration of dexamethasone and infection (PADDI) trial protocol: rationale and design of a pragmatic multicentre non-inferiority study. BMJ open. 2019 Sep 1;9(9):e030402.

Corcoran TB, Myles PS, Forbes AB, Cheng AC, Bach LA, O’Loughlin E, et al. Dexamethasone and surgical-site infection. New England Journal of Medicine. 2021 May 6;384(18):1731-41.

Soliman R, Nofal H. The effect of perioperative magnesium sulfate on blood sugar in patients with diabetes mellitus undergoing cardiac surgery: a doubleblinded randomized study. Ann Card Anaesth 2019; 22: 151e7

Levy N, Lirk P. Regional anaesthesia in patients with diabetes. Anaesthesia 2021; 76: 127e35

Francia P, Anichini R, Seghieri G, De Bellis A, Gulisano M. History, prevalence and assessment of limited joint mobility, from stiff hand syndrome to diabetic foot ulcer prevention: a narrative review of the literature. Curr Diabetes Rev 2018; 14: 411e26

Stevanovic K, Sabljak V, Toskovic A, Kukic B, Stekovic J, Antonijevic V, Kalezic N. Anaesthesia and the patient with diabetes. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2015 Jul 1;9(3):177-9.

Gottschalk A, Rink B, Smektala R, Piontek A, Ellger B. Spinal anesthesia protects against perioperative hyperglycemia in patients undergoing hip arthroplasty. J Clin Anesth 2014; 26: 455e60

National Diabetes Inpatient Audit (NaDIA). Harms; 2020. p. 4. Chapter number 1. Available from: https://www.hqip.org. uk/resource/national-diabetesinpatient-audit-nadiaharms-2020/#.Y91vz-zP3Fo. [Accessed 3 February 2023].

Karunarathna I, Kusumarathna K, Jayathilaka P, Rathnayake B, Gunathilake S, Senarathna R, et al. Comprehensive Management of Diabetes Mellitus in the Perioperative Setting: An Anesthesia Perspective. Uva Clinical Lab. Retrieved from ResearchGate. 2024.

Buggy DJ, Nolan R, Coburn M, Columb M, Hermanides J, Hollman MW, et al. Protocol for a prospective, international cohort study on the management and outcomes of perioperative care among European diabetic patients (MOPED). BMJ open. 2021 Sep 1;11(9):e044394.